A new inter partes review, IPR2026-00391, was filed on June 5, 2026, at the Patent Trial and Appeal Board naming Teladoc Health, Inc. in the proceeding. The filing places another spotlight on the digital health and telemedicine patent landscape, where platform functionality, remote care workflows, and software-driven healthcare delivery continue to generate high-stakes validity disputes.

At this early stage, the PTAB docket identifies the proceeding by title but may not yet reflect the full set of publicly available petition details practitioners typically watch for, including the specific patent number, the complete alignment of petitioner and patent owner, and the precise prior-art combinations asserted in the challenge. As those papers become available, counsel will want to focus on the patent claims targeted for review, the technology at issue, and whether the petition centers on software implementation, healthcare communication systems, patient monitoring, or broader virtual-care infrastructure.

In general, an IPR petition asks the PTAB to cancel patent claims as unpatentable under anticipation or obviousness theories based on patents and printed publications. Once the petition and supporting exhibits are accessible, the key questions will be familiar ones: Which claims are challenged? What prior art forms the core grounds for review? Is the petitioner relying on a straightforward obviousness combination, or does the filing test the boundaries of motivation-to-combine and reasonable expectation of success in a regulated healthcare context?

This case is worth tracking for several reasons. First, telehealth patents often sit at the intersection of software, medical workflow, and data communication, making them fertile ground for institution fights over claim construction, analogous art, and whether the alleged invention is truly technical or largely an implementation of known practices on conventional systems. Second, Teladoc is a prominent player in remote care, so any PTAB activity involving its portfolio may carry broader strategic implications for competitors, licensing discussions, and parallel district court litigation. Third, petitions in the digital health space can offer useful signals on how challengers are framing prior art against modern healthcare platforms, particularly where user interfaces, provider-patient interactions, and backend coordination tools are concerned.

For patent prosecutors, litigators, and in-house IP teams, IPR2026-00391 is a proceeding to monitor as the petition, preliminary response, and any institution decision flesh out the dispute. The case may provide a useful read on claim durability in telemedicine-related patents and on how parties are positioning software-centric healthcare inventions before the Board.

View full case on Docket Alarm